Cardiovascular Diseases

Patient-Reported Outcomes Similar with Intensive BP Target

Patient-reported outcomes among participants who received intensive BP treatment were similar to those among participants who received standard treatment. A total of 9361 participants with hypertension at high risk for cardiovascular disease were randomly assigned to a systolic blood-pressure (SBP) target of less than 120 mm Hg or 140 mm Hg. Participants who received intensive treatment received an average of one additional antihypertensive medication, and the SBP was 14.8 mm Hg lower in the group that received intensive treatment than in the group that received standard treatment. There were no significant differences in physical, mental and psychological scores, satisfaction and adherence between the two groups. The intensive treatment was also cost-effective. Source: http://www.nejm.org/

hyangiu

Recent Posts

Early-Life Sugar Restriction Protective on T2D and High Blood Pressure

A study comparing UK adults conceived just before or after sugar rationing ended found that…

2 weeks ago

Cold Weather Linked to Higher MI Risk

A Chinese nationwide case-crossover study revealed that lower temperatures were associated with higher risks of…

3 weeks ago

Brighter Nights and Darker Days Predict Higher Mortality Risk

A prospective cohort study suggests that personal exposure to brighter nights and darker days causes…

1 month ago

Mindfulness-Based Stress Reduction on Par with Escitalopram for Anxiety Disorders

Both clinician-rated and patient-reported outcomes suggested that mindfulness-based stress reduction (MBSR) was well-tolerated with comparable…

1 month ago

Key Messages of 2024 ESC Guidelines for High BP

The number of individuals with high blood pressure (BP) is increasing worldwide. The trajectory of…

3 months ago

CRP, LDL Cholesterol, and Lipoprotein(a) Levels Predictive of CVD

A single combined measure of high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a)…

3 months ago

This website uses cookies.